MS4A1 and neoplasm: To confirm this, we next assessed tumor samples histologically to gain insights into the density and distribution of B cells isotypes by multiplex fluorescent IHC staining (mIHC), and demonstrated that neoadjuvant chemoimmunotherapy promoted more intratumoral CD20+ B cells infiltration (mean 7.59% versus 14.25%, Fig. 2D, E).